UC San Diego Shiley Eye Institute UC San Diego Shiley Eye Institute The Viterbi Family Department of Ophthalmology UC San Diego Shiley Eye Institute
by name
Afshari, Natalie A. Brown, Stuart I. Camp, Andrew Chao, Daniel L. Do, Jiun Ferrara, Napoleone Ferreyra, Henry A. Freeman, William R. Goldbaum, Michael H. Granet, David B. Haw, Weldon W. Heichel, Chris W. Kikkawa, Don O. Korn, Bobby S. Lee, Jeffrey E. Lin, Jonathan H. Liu, Catherine Y. Nguyen, Thao P. Nudleman, Eric Robbins, Shira L. Savino, Peter J. Slight, Rigby Vasile, Cristiana Weinreb, Robert N. Welsbie, Derek S. Zhang, Kang
by specialty
Comprehensive Ophthalmology Cornea & Refractive Surgery Glaucoma Neuro-Ophthalmology Ophthalmic Genetics Ophthalmic Pathology Ophthalmic Plastic & Reconstructive Surgery Optometry & Low Vision Pediatric Ophthalmology & Eye Alignment Disorders Refractive Surgery / LASIK Retina & Vitreous Thyroid Eye Clinic
by condition
AMD (Age-related Macular Degeneration) Cataracts Corneal Conditions Cosmetic Surgery Diabetic Retinopathy Eye Movement Disorders Glaucoma Hereditary (Genetic) Disorders Low Vision Neuro-Ophthalmic Conditions Ophthalmic Plastic and Reconstructive Surgery Pediatric Conditions Refractive Errors Retinal Diseases Strabismus (Strabimus) Thyroid Eye Disease

Eye drops hold promise for reversing cataracts

Original Article: http://www.cbsnews.com/news/eye-drops-hold-promise-for-reversing-cataracts/

By PAULA COHEN / CBS NEWS / July 28, 2015, 2:02 PM


More than 20 million Americans have cataracts, a leading cause of vision loss and blindness, and right now surgery is the only available option to correct the problem. But new research raises the hope that someday, cataracts could be cured with simple eye drops.

Cataracts occur when the normally transparent lens of the eye gradually clouds over due to an accumulation of proteins that malform and clump together. The condition often develops as people get older; the National Eye Institute estimates that by the age of 80, more than half of all Americans either have a cataract or have had surgery to remove one.

Now researchers from the University of California, San Diego have discovered a promising alternative to surgery: an eye drop that effectively reversed cataracts in animal testing. Their findings are published in the journal Nature.

Feast your eyes: 8 nutrients to help protect your sight
Their work began with the cases of three children who had a severe cataract condition that ran in their family. The scientists sequenced the children's genomes and identified a genetic mutation that interfered with the production of lanosterol, a naturally occurring steroid in the body. From that clue, they decided to test whether lanosterol might have the ability to prevent or even eliminate cataracts.

They tested it first in lab cultures, then in the cataract lenses of rabbits, and finally on 7 dogs from 3 species (black Labrador, Queensland Heeler and Miniature Pinscher ) who were suffering from adult-onset cataracts, which can happen in canines as well as humans.

For the dogs' treatment, they sedated the animals and injected lanosterol (100 mg)-loaded nanoparticles into the vitreous cavity of the eye, the area behind the lens which is filled with a gel-like substance called the vitreous humor. The treatment eyes then received lanosterol in topical eye drops, one drop three times a day for 6 weeks.

"Treatment by lanosterol," the researchers write, "significantly decreased preformed protein aggregates both in vitro and in cell-transfection experiments."

Before and after photos showing dogs' cataracts diminished after lanosterol treatment. LING ZHAO ET. AL./NATURE
The dogs who received the treatment showed notable improvement in their cataracts, graded on a scale from zero (no cataract) to 3 (extensive opacity of the entire lens).

"I was pleasantly surprised, even in principle, this treatment should work," one of the authors of the study, Dr. Kang Zhang, professor of ophthalmology and chief of ophthalmic genetics at UC San Diego, told CBS News.

Other scientists in the field were impressed by the results.

In a commentary published in Nature to accompany the study, J. Fielding Hejtmancik, of the Ophthalmic Genetics and Visual Function Branch of the National Eye Institute, suggested the research could lead to non-surgical prevention and treatment of cataracts.

"The potential for this finding to be translated into the first practical pharmacological prevention, or even treatment, of human cataracts could not come at a more opportune time," he writes.

"This is a really comprehensive and compelling paper - the strongest I've seen of its kind in a decade," Jonathan King, a molecular biologist at Massachusetts Institute of Technology who researches cataract proteins, told Science magazine. "They discovered the phenomena and then followed with all of the experiments that you should do - that's as biologically relevant as you can get."

Before testing can begin in humans, Zhang said the team will need to check the toxicity of lanosterol, even though it is "a product of our own body. Then we will need to formulate the drug as the most efficient eye drop for a human trial."

In a Nature podcast, Zhang said he and his colleagues hope to begin human trials within a year.

© 2015 CBS Interactive Inc. All Rights Reserved.


To make an appointment, call
(858) 534-6290
All appointments are prioritized on the basis of medical need.

Clinic Hours

Monday - Friday
7:00am - 5:00pm
7:45am - 2:00pm

Phone Hours

Monday - Friday
8:00am - 4:30pm
8:00am - 2:00pm

Email Us

Have Questions? Contacting us has never been easier. Leave us a question or comment today!


Complete patient parking information available on the Contact Us page under Directions.

Whats Your Symptom Disclaimer

The information contained in this online site is intended to provide accurate and helpful health information for the general public. It is made available with the understanding that the author and publisher are not engaged in rendering medical, health, psychological, or any other kind of personal professional services on this site. The information should not be considered complete and does not cover all diseases, ailments, physical conditions or their treatment. It should not be used in place of a call or visit to a medical, health or other competent professional, who should be consulted before adopting any of the suggestions in this site or drawing inferences from it.

The information about drugs contained on this site is general in nature. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medicines mentioned, nor is the information intended as medical advice for individual problems or for making an evaluation as to the risks and benefits of taking a particular drug.

The operator(s) of this site, and the publisher, specifically disclaim all responsibility for any liability, loss or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the material on this site.

Click Here To Accept

Email Us

First Name*
Last Name*

Required *